98 related articles for article (PubMed ID: 31545162)
1. CORRIGENDUM to: Correlation of Apolipoprotein B mRNA-editing Enzyme, Catalytic Polypeptide- like 3G Genetic Variant rs8177832 with HIV-1 Predisposition in Pakistani Population.
Iqbal K; Imran M; Ullah S; Jamal M; Waheed Y
Curr HIV Res; 2019; 17(2):146. PubMed ID: 31545162
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Apolipoprotein B mRNA-editing Enzyme, Catalytic Polypeptide- like 3G Genetic Variant rs8177832 with HIV-1 Predisposition in Pakistani Population.
Iqbal K; Imran M; Ullah S; Jamal M; Waheed Y
Curr HIV Res; 2018; 16(4):297-301. PubMed ID: 30338740
[TBL] [Abstract][Full Text] [Related]
3. HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.
Compaore TR; Diarra B; Assih M; Obiri-Yeboah D; Soubeiga ST; Ouattara AK; Tchelougou D; Bisseye C; Bakouan DR; Compaore IP; Dembele A; Djigma WF; Simpore J
BMC Infect Dis; 2016 Jul; 16():336. PubMed ID: 27449138
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Kanari Y; Magri G; Trabattoni D; Naddeo V; Lopalco L; Clivio A; Cesana E; Fasano F; Bergamaschi C; Mazzotta F; Miyazawa M; Clerici M
J Infect Dis; 2007 Apr; 195(7):960-4. PubMed ID: 17330785
[TBL] [Abstract][Full Text] [Related]
5. Effect of apolipoprotein B mRNA-editing catalytic polypeptide-like protein-3G in cervical cancer.
Xu Y; Leng J; Xue F; Dong R
Int J Clin Exp Pathol; 2015; 8(10):12307-12. PubMed ID: 26722417
[TBL] [Abstract][Full Text] [Related]
6. Association of single nucleotide polymorphisms of APOBEC3G with susceptibility to HIV-1 infection and disease progression among men engaging in homosexual activity in northern China.
Li Q; Qiao Y; Zhang G; He N; Zhang X; Jia X; Sun H; Wang C; Xu L
Arch Virol; 2017 Jan; 162(1):259-268. PubMed ID: 27730383
[TBL] [Abstract][Full Text] [Related]
7. Potential roles of placental human beta-defensin-3 and apolipoprotein B mRNA-editing enzyme catalytic polypeptide 3G in prevention of intrauterine transmission of hepatitis B virus.
Bai X; Tian T; Wang P; Yang X; Wang Z; Dong M
J Med Virol; 2015 Mar; 87(3):375-9. PubMed ID: 25196417
[TBL] [Abstract][Full Text] [Related]
8. Host apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virus.
Peng ZG; Zhao ZY; Li YP; Wang YP; Hao LH; Fan B; Li YH; Wang YM; Shan YQ; Han YX; Zhu YP; Li JR; You XF; Li ZR; Jiang JD
Hepatology; 2011 Apr; 53(4):1080-9. PubMed ID: 21480314
[TBL] [Abstract][Full Text] [Related]
9. Zinc-mediated binding of a low-molecular-weight stabilizer of the host anti-viral factor apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G.
Radwan MO; Sonoda S; Ejima T; Tanaka A; Koga R; Okamoto Y; Fujita M; Otsuka M
Bioorg Med Chem; 2016 Sep; 24(18):4398-4405. PubMed ID: 27475536
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effect of apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members on the activity of cellular microRNAs.
Zhang H
Prog Mol Subcell Biol; 2010; 50():71-83. PubMed ID: 19841882
[TBL] [Abstract][Full Text] [Related]
11. An anti-HIV-1 compound that increases steady-state expression of apoplipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G.
Ejima T; Hirota M; Mizukami T; Otsuka M; Fujita M
Int J Mol Med; 2011 Oct; 28(4):613-6. PubMed ID: 21725586
[TBL] [Abstract][Full Text] [Related]
12. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
[TBL] [Abstract][Full Text] [Related]
13. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
[TBL] [Abstract][Full Text] [Related]
14. The evolution of apolipoprotein B and its mRNA editing complex. Does the lack of editing contribute to hypertriglyceridemia?
Damsteegt EL; Davie A; Lokman PM
Gene; 2018 Jan; 641():46-54. PubMed ID: 29031774
[TBL] [Abstract][Full Text] [Related]
15. Protecting APOBEC3G: a potential new target for HIV drug discovery.
Stopak K; Greene WC
Curr Opin Investig Drugs; 2005 Feb; 6(2):141-7. PubMed ID: 15751736
[TBL] [Abstract][Full Text] [Related]
16. [Progress in the study of HIV-1 Vif and related inhibitors].
Li ZY; Zhan P; Liu XY
Yao Xue Xue Bao; 2010 Jun; 45(6):684-93. PubMed ID: 20939174
[TBL] [Abstract][Full Text] [Related]
17. Structure and real-time monitoring of the enzymatic reaction of APOBEC3G which is involved in anti-HIV activity.
Furukawa A; Nagata T; Matsugami A; Habu Y; Sugiyama R; Hayashi F; Kobayashi N; Yokoyama S; Takaku H; Katahira M
Nucleic Acids Symp Ser (Oxf); 2009; (53):87-8. PubMed ID: 19749273
[TBL] [Abstract][Full Text] [Related]
18. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
[TBL] [Abstract][Full Text] [Related]
19. NMR assignments and the identification of the secondary structure of the anti-retroviral cytidine deaminase.
Furukawa A; Nagata T; Habu Y; Sugiyama R; Hayashi F; Yokoyama S; Takaku H; Katahira M
Nucleic Acids Symp Ser (Oxf); 2008; (52):183-4. PubMed ID: 18776314
[TBL] [Abstract][Full Text] [Related]
20. Arsenic programmes cellular genomic-immunity through miR-2909 RNomics.
Kaul D; Sharma S; Sharma M; Arora M; Arora M
Gene; 2014 Feb; 536(2):326-31. PubMed ID: 24361962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
